Association between antidepressant use and the risk of type 2 diabetes: a multi-stage Mendelian randomization study.
Genetic evidence suggesting medication-specific associations between antidepressant use liability and T2D susceptibility is provided, highlighting that the metabolic effects of individual antidepressants may vary, thus, warranting further studies to determine the clinical relevance of the findings.